ASX 200 sinks 1.3%, Cochlear soars, TWE sours

The S&P/ASX 200 Index (ASX:XJO) dropped 1.3% on Friday. The Cochlear Limited (ASX:COH) share price climbed around 9%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) fell by 1.3% today to 6,794 points.

Reporting season continues to roll on as some companies impress the market.

Here are some of the highlights from today:

a woman

Cochlear Limited (ASX: COH)

The Cochlear share price soared by almost 9% today after the healthcare business reported its result for the six months to 31 December 2020.

Cochlear said that its sales revenue fell by 4% to $742.8 million. Underlying earnings before interest and tax (EBIT) declined by 4% to $175.6 million and underlying net profit after tax (NPAT) dropped 6% to $125.3 million.

The statutory net profit after tax (NPAT) jumped 50% to $236.2 million with $59 million of patent litigation-related tax and other benefits, $34.7 million of innovation fund gains and $17.2 million of COVID-19 government assistance. However, the company plans to give back the jobkeeper payments to the government.

The ASX 200 company's board decided to pay a dividend of $1.15 per share, representing a dividend payout ratio of 60%.

In FY21, Cochlear is expecting to deliver underlying net profit of between $225 million and $245 million. This would represent an increase of between 46% to 59% compared to the prior corresponding period. It's becoming increasingly confident of the resilience of its hearing implant business.

It also expects to target a dividend payout ratio of 70% of underlying net profit and anticipates returning to the 70% ratio as markets continue to improve.

Inghams Group Ltd (ASX: ING)

Poultry business Inghams was another of today's top performers in the ASX 200 after reporting its FY21 half-year result.

Inghams reported that its core poultry volume rose by 4% to 224.6kt. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) went up 4.3% to $218.6 million and underlying NPAT increased by 28.4%.

The poultry business reported that good progress has been achieved in the reduction of frozen poultry inventory arising in FY20 due to COVID-19, down $42.3 million during the half and now close to normal levels.

Inghams' board decided to declare a fully franked dividend of 7.5 cents per share, which was an increase of 2.7%. This reflected a dividend payout ratio of 74.3% of underlying NPAT.

The CEO and managing director of Inghams, Jim Leighton, said:

These results have been delivered despite the continued impact of COVID-19, ongoing high realised feed prices and the partial closure of Australia's poultry export channels due to industry biosecurity issues in Victoria. Our strategy is driving performance and delivering improved returns.  

Treasury Wine Estates Ltd (ASX: TWE)

The Treasury Wine Estates share price fell by 6% today, making it one of the worst performers in the ASX 200. It has given up some of the gains made yesterday after it rocketed higher.

Today, it was reported by the Australian Financial Review that Michelle Brampton, who is the managing director of the Treasury Wine Europe, Middle East and Africa (EMEA) business, has resigned and will be leaving in the next few months after TWE announced it was restructuring into new three new business units.

The reason why she reportedly resigned is that despite being a compelling candidate to lead one of the new business units, having held various positions around the company for many years, she was overlooked.

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia owns shares of and has recommended Treasury Wine Estates Limited. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile but positive Tuesday.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Market News

Why I'd buy DroneShield and these ASX 200 shares next month

These ASX shares offer a mix of growth, resilience, and long-term opportunity.

Read more »

A kid and his grandad high five after a fun game of basketball.
52-Week Highs

Telstra just hit a 10-year high. Has this ASX income giant still got more to give?

Telstra’s breakout to a multi-year high is turning heads.

Read more »

An arrow going upwards with a road sign saying 'IPO ahead'.
IPOs

I won't be buying the Koala stock IPO. Here's why

Koala is the latest company to go public on the ASX.

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 4DMedical, New Hope, Santos, and St George Mining shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Share Fallers

These 3 dirt-cheap ASX shares are tipped to climb another 50-90%

These shares are now trading at super low prices.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »